Communication about carrier testing within hemophilia A families
Abstract
Genetic diseases are family diseases. Although there is considerable research on how individuals decide to have genetic testing and their individual reactions to testing, there is limited research on the familial context of genetic testing. In the present study, we focus on three aspects of the family context of genetic testing for hemophilia A carrier status among women at risk to be carriers. We look at the extent to which there was discussion of carrier testing for hemophilia before we offered DNA-based carrier testing to these at-risk women; with which family members these tested women communicated the results of their carrier testing; and concerns these women had about communicating their carrier test results with relatives, including their children. Data suggest that members of families with hemophilia discussed carrier testing prior to study participation, that the communication of testing information within families was selective, not universal, largely following gender lines for this X-linked disorder, and that there was limited concern about communicating carrier status information to children and other relatives. These data reinforce observations that families are social systems, and within these systems information is selectively communicated. A more complete understanding of how families communicate genetic test information will enable providers to develop more effective means of assisting individuals in handling the familial communication aspects of genetic testing. © 2002 Wiley-Liss, Inc.
INTRODUCTION
“Genetic diseases are family diseases.” This phrase, or one similar to it, is common in psychosocial research on genetic testing and in commentaries from professionals who work with patients with genetic diseases (cf. the spring 1999 issue of Families, Systems and Health). Basic molecular research is helping to clarify what such a statement may mean genetically for the biological family. While there is considerable research to date on how individuals decide to be tested and their individual reactions to testing, there is limited research on the familial context of genetic testing.
The concept of the familial context of genetic testing raises many questions. For example, who is family? Who is included and excluded from this primary social unit and who decides on membership? Should family be biologically defined, socially defined, or a mix? In what ways does the family serve to encourage and facilitate or discourage and hinder the involvement of family members in genetic testing? Does the family, however defined, provide support for members who undergo testing? Are genetic conditions, or at least some genetic conditions, considered family secrets that are best not discussed and not shared within or outside the family? There are many more questions [Imber-Black, 1993].
Unless genetic testing is significantly different than many other forms of medical testing, one would suspect that the family context serves to help individual members assess their need for genetic testing, interpret the results of such testing, and cope with testing results [Franks et al., 1992]. But it can be argued that genetic testing is different than many other types of medical testing. It is often the case that what a person learns about themselves from genetic testing can have significant implications for other family members. When one family member is tested, in a sense other family members are tested also.
In the present study, we focus on three aspects of the family context of genetic testing for hemophilia A carrier status. We look at the extent to which there was discussion of genetic carrier testing for hemophilia A before we offered recently developed DNA-based testing to at-risk women and the role of relatives in these women's decisions to have DNA-based testing; once tested, with which family members did the women communicate the results of their DNA-based testing; and whether the tested women have concerns about communicating carrier test results to relatives, including their children.
While there are many other family aspects to genetic testing, we think these three aspects are especially important. For example, it is likely to be the case, at least in families with a history of genetic disease, that there will be communication about the disease and its implications for family members before any formal testing is available. In the case of hemophilia, non–DNA-based carrier testing (linkage analysis) has been available for some years. This availability is likely to make these families more experienced in handling genetic carrier testing information than families with genetic diseases for which carrier testing is new. The more informed counselors are about such family communication of genetic testing, the more effective they can be in their approach to educating patients and family members about developments in genetic testing.
Additionally, an understanding of which tested individuals communicate the results of their testing within the family as well as concerns they have about such communication are important issues. One common assumption in much clinical genetic practice is that family members do, or will if requested, communicate the results of their testing, or at least communicate the availability of genetic testing, with relevant family members. This may or may not be the case and may be affected by concerns women have about communicating such information within the family. The more insight we have of the problems and issues families confront in communicating genetic testing information, the more educators and counselors will be able to develop effective means of assisting tested individuals handle this familial aspect of genetic testing.
Background
Research describing the communication of genetic information within families is limited. The research that is available encompasses a variety of diseases. Furthermore, some studies report the discussion of risk information among family members, some focus on communicating carrier test results, while others focus on discussion of the genetic aspects of the diseases themselves. This makes it difficult to generalize about family genetic testing communication patterns and practices.
Research suggests that discussion of genetic information within families is likely influenced by a number of factors. While examining public interest in genetic testing for colon cancer susceptibility, Smith and Croyle [1995] asked respondents to consider the hypothetical situation of testing positive for a gene associated with colon cancer. Respondents without health insurance and those who were widowed were least likely to indicate that they would share their test result with family members. Smith and Croyle [1995] argue that widowed individuals may be less likely to share test results because they may have fewer individuals with whom to share the information. Those without insurance may be less likely to share results due to concerns about obtaining insurance in the future. The majority of respondents reported that they would first talk either to a physician or to their spouse about receiving a positive test result. Respondents reporting a family history of colon cancer would be more likely to discuss their test result first with a physician than those not reporting a family history of colon cancer. Smith and Croyle [1995] speculate that those with a family history of colon cancer may be more familiar with the disease and thus may see test results more as a personal medical problem than as something requiring communication with family members.
Several studies assess the discussion of genetic information within the family. Denayer et al. [1990] found that 80% of the parents of a child with cystic fibrosis (CF) informed their brothers and sisters about the genetic aspect of CF. Another study focusing on CF found that only one-third of the siblings of CF patients had disclosed their carrier test results to other unaffected brothers and sisters [Fanos and Johnson, 1995]. Though discussion of genetic information within families is occurring, communication of genetic test results to relatives is not universal within families and seems to be influenced, at least in part, by the genetics of the particular disease involved. For example, higher rates of communicating breast/ovarian genetic test results to female than male relatives have been observed [Green et al., 1997; Hughes et al., 1999]. Women at risk of carrying the hemophilia A gene indicated that they discussed issues related to hemophilia more often with sisters than with brothers [Varekamp et al., 1992].
Evidence that individuals do not always share information about genetic risk with other family members has been found in three studies involving inherited balanced translocations. Suslak et al. [1985] found that 20% of the first-degree relatives of balanced translocation carriers had not been informed of their risk of being a carrier. Wolff et al. [1989] report that families with an affected child or relative shared genetic risk information with family members more often than families in which the adverse effects of an unbalanced karyotype was not as apparent. Ayme et al. [1993] assessed the diffusion of genetic information within families by evaluating which relatives of carriers of a balanced chromosomal abnormality had received genetic testing. Rather than asking carriers with whom they had shared risk information, the authors evaluated karyotyping rates of at-risk relatives. They found that 44% of the at-risk relatives had been tested. In 63.2% of the families, less than half of the at-risk relatives had been karyotyped.
Researchers are extending the study of communication of genetic information within families to include psychological effects. Lerman et al. [1998] found that BRCA1/2 carriers who communicated their test results to their sisters exhibited a small decrease in psychological distress, while carriers who did not disclose their test results showed a small increase in distress. The nature of the genetic tests performed may also affect discussion of test results in families and subsequent psychological effects. For example, individuals undergoing genetic testing for cancer susceptibility may share their test results in part so that other family members can undergo appropriate risk management strategies and screening. The desire to help relatives has been shown to be related to the desire to have genetic testing for colon cancer [Vernon et al., 1999]. Also, the anticipated impact that test results could have on family members has been determined to be an important factor in deciding whether to undergo genetic testing for Huntington disease [Binedell et al., 1998].
A unique aspect of the present study involves examining the extent to which there was discussion of hemophilia A carrier testing before offering DNA-based carrier testing to out study population. A review of the literature revealed one other study assessing family communication before as well as after genetic testing. Green et al. [1997] found that 36 of the 46 women in their study approached at least one other relative for information before going to genetic counseling for breast/ovarian cancer. No woman with a living mother approached any other relative for information, indicating the pivotal role of key informant that mothers played in this sample. After the counseling session, 88% of the women shared their consultation letter with at least one first-degree relative. However, nearly all of the women had at least one first- or second-degree relative whom they were not intending to inform, most commonly due to not being in touch. Interestingly, information was generally revealed during family events, such as family reunions and holiday get-togethers. This was apparently done to avoid alarming family members by contacting them for the sole purpose of sharing cancer risk information.
Research assessing the discussion of genetic information within families affected by hemophilia A is limited. In one study, Varekamp et al. [1992] surveyed female relatives of hemophilia A patients. Respondents revealed that their partners and mothers were the family members with whom they generally discussed the hereditary nature of hemophilia and carrier testing. One out of five women surveyed indicated that the hereditary nature of hemophilia had never been discussed in their parental homes.
Examining the methodologies, research designs, and measurement techniques used in evaluating disclosure of human immunodeficiency virus (HIV infection) status may be informative for researchers exploring communication of genetic carrier test results. Several researchers in the HIV field refer to a process of disclosure. Not only is disclosure of HIV status selective [Leask et al., 1997; Kadushin, 2000], but it occurs in stages. These include adjusting to the diagnosis, assessing one's disclosure skills, deciding whom to tell, and anticipating responses [Kimberly et al., 1995]. There may be similar stages that people undergoing genetic testing go through in communicating test results with relatives. Motivations for disclosure of HIV status [Holt et al., 1998], factors associated with disclosure [Stein et al., 1998], and consequences of disclosure [Mansergh et al., 1995] have been given attention also. HIV status disclosure has been examined for its multiple roles as a stressor, as well as a means of coping with the disease and gaining social support [Cline and Boyd, 1993; Holt et al., 1998]. These factors may also be operative with respect to family communication about genetic testing results.
There are some similarities between HIV and genetic carrier status disclosure. Both HIV and carrier status disclosure may lead to stigmatization within as well as outside the family, such as employment and insurance discrimination. Furthermore, the information provider probably considers the emotional coping ability of those with whom they choose to share the information. An important difference, of course, is there is no risk of transmission involved in genetic diseases, while those who are HIV-positive often reveal their disease status to avoid infecting others, such as health care workers and sexual partners [Cline and Boyd, 1993].
MATERIALS AND METHODS
Study Characteristics
The data reported here come from a National Human Genome Research Institute-funded study of hemophilia carrier education, testing, and counseling of at-risk relatives of individuals with hemophilia A (Sorenson, “Hemophilia ‘A’ Carrier Testing: Acceptance and Reactions”). The purpose of this study was to examine the level of interest in and acceptance of direct mutation carrier testing in this population. This study was reviewed and approved by the local institutional review broad. Additionally, a federal writ of confidentiality was obtained to provide added privacy protection for the study populations.
Study Populations
The research involved two populations, patients and their at-risk female relatives.
Patients
All patients were followed at two large Southeastern hemophilia clinics. Eligibility criteria included clinical diagnosis of severe, mild, or moderate hemophilia A; patients were 18 or older, or their parent consented to participation; patients had at-risk relatives living in a designated geographic area; spoke English; were willing to provide blood for DNA mutation analyses; and patient or parent read and signed the informed consent form.
Prior to a regularly scheduled clinic visit, the patient/parent received a letter from the clinic director. The letter outlined the study and solicited participation. It informed patients that should the project be able to identify the mutation in their family, they would be asked to inform their at-risk relatives of the availability of free pretest genetic education, mutation testing, and posttest genetic counseling.
Unless the patient or their parent informed us otherwise, at their next regularly scheduled clinic visit a research genetic counselor approached the patient, reviewed the study, and solicited their informed consent. If the patient consented, the counselor created a pedigree based on the patient's/parent's family knowledge. Patients/parents also completed a four-page self-administered questionnaire.
Relatives
Once patients were informed that the mutation in their family had been identified, research staff worked with participants to facilitate their contacting eligible at-risk female relatives. As per institutional review board requirements, relatives were initially informed of the study by the patient/parent or another family member. To facilitate this contact, these people were provided with packets that they could send to their eligible relatives. Packets included an introductory letter and fact sheet about the study, an educational brochure on hemophilia and DNA-based carrier testing, a response sheet to assist with completing the baseline telephone interview, and a copy of the informed consent form.
Once the family contact provided the counselor with the telephone number of an interested relative, either the counselor or a research assistant called the relative. When contacted by research personnel, the woman then learned more about the study and decided if she would have free genetic counseling and carrier testing. Counseling and blood drawing for mutation testing were done in the woman's home or a mutually convenient location.
Eligible relatives were those who had a 12.5% or greater risk of being a hemophilia gene carrier; had not already had direct DNA mutation testing; lived in North or South Carolina, Georgia, Virginia, or West Virginia, or were willing to travel to this area; were at least 18; were not pregnant; spoke English; had access to a telephone; and read and signed the informed consent form. Relatives completed a baseline telephone interview as well as a 6- and 12-month telephone interviews.
The baseline interview collected information on numerous topics, including previous carrier testing, prior discussion of carrier testing within the family, knowledge of and attitudes toward hemophilia and carrier testing, and reproductive history and plans. The 6 and 12-month interviews covered much of the information collected at baseline. The genetic counselor trained research staff to conduct all interviews. If questions about carrier testing or the clinical aspects of hemophilia arose which the interviewer could not handle, the interviewer would inform the counselor, who would then contact the relative. Data from the baseline and 6-month interviews are reported here.
RESULTS
Patients
Of 127 patients contacted in the clinic, 100 were eligible for study inclusion. Of these, 87 completed the four-page questionnaire. The remainder chose not to participate in the research. Table I presents information about these patients. The majority of patients had severe hemophilia and were not the only one in their family with the disease. Just over two-thirds were Caucasians and just over three-fourths were Protestant. A majority reported an annual income of less than $30,000 per year. Because of the young age of many of these men, a majority had never been married.
Severity of hemophilia (n = 87) | |
Severe | 69.0% |
Moderate | 16.1% |
Mild | 14.9% |
Patient education (n = 57) | |
High school or less | 50.9% |
Some college | 28.1% |
College degree plus | 21.1% |
Religion (n = 87) | |
Protestant | 76.5% |
Other | 14.1% |
No organized religion | 9.0% |
Men with hemophilia in family (n = 63) | |
One | 36.5% |
More than one | 63.5% |
Mother's education (n = 30) | |
High school of less | 36.7% |
Some college | 33.3% |
College degree plus | 30.0% |
Family income (n = 78) | |
<$30,000 | 56.4% |
$30,001 to $50,000 | 21.8% |
>$50,0001 | 21.8% |
Age (n = 87) | |
17 or less | 33.3% |
18 to 35 | 26.4% |
36 to 54 | 33.3% |
55 or more | 6.9% |
Ethnicity (n = 87) | |
Caucasian | 67.8% |
African American | 24.15% |
Other | 8.0% |
Marital status (n = 78) | |
Never married | 50.0% |
Presently married | 36.1% |
Other | 13.9% |
Table II presents information on patient's beliefs, attitudes, and prior experience discussing hemophilia in their families. Surprisingly, only 57.9% recalled discussing hemophilia inheritance with someone in the past. About 70% thought their relatives had a low or medium chance of having a child with hemophilia. Nearly 60% had discussed carrier testing with relatives in the past and just over 70% reported an obligation to inform relatives about the study. About 80% reported hemophilia to be a severe or very severe disease. Only four (5.3%) thought our asking them to contact their relatives constituted an invasion of their, their families', or their relatives' privacy.
Someone discussed hemophilia inheritance with you (n = 76) | |
Yes | 57.9% |
No | 42.1% |
Chance relatives could have child with hemophilia (n = 80) | |
Low | 43.8% |
Medium | 26.3% |
High | 30.0% |
Discussed carrier testing with relatives in the past (n = 76) | |
Yes | 57.9% |
No | 42.1% |
Importance of at-risk women to have carrier testing (n = 86) | |
Not | 2.3% |
Somewhat | 16.3% |
Very important | 81.4% |
Have an obligation to inform relatives about this study (n = 76) | |
Yes | 71.1% |
No | 28.9% |
Our asking you to contact relatives an invasion of privacy (n = 76) | |
Yes | 5.3% |
Unsure | 6.6% |
No | 88.2% |
Impact of hemophilia on a family (n = 87) | |
Slight | 36.8% |
Problem | 19.5% |
Major | 43.7% |
Severity of hemophilia (n = 86) | |
Mild | 19.8% |
Severe | 33.7% |
Very severe | 46.5% |
Relatives
Of 262 at-risk relatives informed about the study by the patient or the patient's mother, 163 (62.2%) agreed to be contacted by the researchers. Of these, 157 (96.9%) were eligible for study inclusion, and of these, 102 (65%) were tested. Ninety-eight of these women completed pre- and posttest questionnaires. These 98 women came from 23 kinships. There was great variability in the number of eligible relatives identified in these kinships, ranging from 1 to 38 eligible relatives. The rate of eligible relative test acceptance within these kinships ranged from 18% to 100%.
Table III presents information on the sociodemographic characteristics of the relatives. Most were married and just under half reported some college or a college degree. The large majority were Caucasians and indicated they were Protestant. Of the 94 relatives reporting household incomes, 38.3% reported an income of less than $30,000 per year and 38.3 reported an income between $30,000 and $50,000 per year. Just over three-fourths were not planning any pregnancies and only 3% were unsure about their reproductive plans.
Age (n = 98) | |
18–35 | 43.9% |
36–55 | 41.8% |
56 plus | 14.3% |
Education (n = 98) | |
High school or less | 52.0% |
Some college | 28.6% |
College plus | 19.4% |
Ethnicity (n = 98) | |
Caucasian | 81.6% |
African American | 17.3% |
Other | 1.0% |
Marital status (n = 98) | |
Currently married | 68.4% |
Other | 31.7% |
Household income (n = 94) | |
<$30,000 | 38.3% |
$30,001 to $50,000 | 38.3% |
>$50,000 | 23.4% |
Religion (n = 98) | |
Protestant | 77.6% |
Catholic | 3.1% |
Other | 19.3% |
Reproductive plans (n = 98) | |
No more children | 78.6% |
More children | 18.4% |
Unsure | 3.1% |
Table IV reports a variety of relatives' experiences at and prior to the baseline interview. About one-third had had prior non–DNA-based carrier testing and over 80% reported thinking about carrier testing in the past year. Most reported some contact with the patient in the past year and only about one-fifth reported they were not psychologically close to the patient. A majority, 69.1%, reported that relatives had influenced their decision to some degree regarding DNA-based carrier testing. As with the patients, the majority of relatives felt our asking the patients to contact them for this study was not an invasion of their, their relatives', or their families' privacy.
Had prior non–DNA-based carrier testing (n = 98) | |
No | 68.4% |
Yes | 31.6% |
Thought about carrier testing in past year (n = 98) | |
No | 16.3% |
Yes | 83.7% |
Contact with patient in past year (n = 98) | |
None | 16.3% |
Some plus | 83.7% |
Psychological closeness to patient (n = 98) | |
Not close | 15.5% |
Close | 84.5% |
Is asking patient to contact you an invasion of your, your relative's, or family's privacy (n = 97) | |
No | 78.6% |
Unsure | 3.1% |
Yes | 18.4% |
To what degree did relatives influence testing decision (n = 97) | |
Not at all | 30.9% |
Some | 39.2% |
Much | 29.9% |
As shown in Table V, mothers were the ones with whom most women reported talking about testing in the year prior to our contacting them, with sisters and the patients' mothers also frequent sources of carrier testing discussion. The discussion of carrier testing with relatives clearly followed gender lines, as one would perhaps expect with an X-linked genetic disease. However, it should be noted that 43.3% reported talking to their relative with hemophilia about carrier testing.
Family members | n | % reporting discussion |
---|---|---|
Mother | 83 | 56.6 |
Sister | 89 | 52.8 |
Patient's mother | 74 | 44.8 |
Patient | 90 | 43.3 |
Aunts | 83 | 19.3 |
Cousins | 92 | 10.9 |
Six months after receiving their test results, relatives were interviewed. They were asked with whom they had discussed their carrier test results (Table VI). Mothers were the family members with whom there was the most test result discussion, followed by partners and sisters. Higher rates of discussion were reported with sisters than with brothers. Additionally, of the 35 relatives with one sister, 71% told her. Of the 30 relatives with one brother, 33% told him. This trend remained in families where there were multiple sisters and brothers. Of the 35 women with more than one sister, 74% told at least one sister while 46% told all their sisters. Of the 25 women with more than one brother, 56% told at least one brother while 28% told all of their brothers. In this population, the communication of DNA-based test results crossed gender lines but still reflected gender differences.
Family members | n | % reporting discussion |
---|---|---|
Mother | 69 | 79.7 |
Partner | 71 | 71.8 |
Sister(s) | 70 | 71.4 |
Brother(s) | 55 | 47.7 |
Father | 48 | 41.7 |
Other relatives | 85 | 37.6 |
Partner's mother | 59 | 23.7 |
Partner's father | 43 | 14.0 |
Relatives were also asked whether they were concerned about talking with other relatives, including their own children, about their test results. Table VII reports whether there were concerns or not. These data suggest that concern about discussing test results with children and other relatives was limited to about one-fifth or less of the population. There was little concern about whom to tell, what to tell, or when to tell children and other relatives.
Concerns about | No | Yes |
---|---|---|
What to tell children (n = 85) | 80.0% | 20.0% |
When to tell children (n = 80) | 83.7% | 16.3% |
Whether to tell relatives (n = 87) | 80.5% | 19.5% |
Which relatives to tell (n = 86) | 86.0% | 14.0% |
What to tell relatives (n = 87) | 88.5% | 11.5% |
While our sample is relatively small, we were able to conduct some correlational analyses identifying factors associated with communication of test results. Because our relatives were clustered within 23 kinships, we used SUDAAN statistical analyses for clustered data (Research Triangle Institute, 1998). All analyses used the chi-square statistic for assessing associations.
These analyses suggested that carriers more than noncarriers (47.6% vs. 6.2%; P < 0.001) reported being concerned about when to tell their children their carrier status. Also, carriers more than noncarriers (38.1% vs. 14.1%; P < 0.056) were likely to report concern about what to tell their children about their carrier status.
Additionally, women planning or unsure about a future pregnancy were more likely to report talking with their partner about their carrier status than those not planning a pregnancy (88% vs. 66%; P < 0.024). Women who had higher levels of education were more likely to talk to their partners than women with less education (P < 0.065). Finally, women who had previous non–DNA-based testing were more likely to discuss their carrier status with their sisters than those who had not had previous testing (P < 0.003).
DISCUSSION
The findings of this study need to be put in context. First, the genetic carrier testing we focused on was for hemophilia A, an X-linked disorder. This may have made the information resulting from carrier testing of more relevance in these kinships to women than men and may have impacted the patterns of carrier test communication we found. It is not clear from existing studies of non–X-linked diseases, such as cystic fibrosis, whether there are strong gender effects with regard to intrafamilial communication. To the extent that genetic testing is like other types of health behavior, one would suspect, however, that there will be some gender effects.
Second, hemophilia is not a fatal disease, but it does have significant implications for the quality of life. While both those with hemophilia and their at-risk relatives considered it a serious disease, the fact that it is not fatal may have dampened some communication about carrier test results with relatives. This would be consistent with the work of Wolff et al. [1989] reported above.
Third, carrier testing for hemophilia, other than DNA-based testing, has been available for several years. While this earlier testing was less precise than DNA-based testing, the prior availability of testing may have contributed to the rates of discussion of carrier testing in the year prior to our contacting at-risk relatives about DNA-based testing by making these families more experienced in and comfortable with discussions of carrier testing.
Fourth, we had access to at-risk female relatives only through the person in their family with hemophilia, that patient's mother, or another family member. This meant, we think, that we enrolled in the study only those women who had decided prior to our contacting them to have DNA-based carrier testing. Their decision to seek such testing may have been made in their initial contact about the study with the patient. This may mean that we recruited into this study those relatives who were most concerned about their hemophilia carrier status, and hence most concerned about sharing it with other relatives.
Fifth, the DNA-based carrier test education, testing, and posttest genetic counseling were offered free to at-risk relatives. This may have increased interest in and possibly discussion of this carrier testing in these families above what would be the case if the at-risk relatives had to rely on insurance or their own funds to pay for such testing.
There are several substantive implications of this study. First, at least in the case of hemophilia A, we think our data suggest that there is a family context in which carrier testing takes place. Members of these families discussed both hemophilia as well as hemophilia carrier testing prior to our approaching them about the new DNA-based carrier detection method. Many had discussed carrier testing with other relatives as well as with the member of the family with hemophilia. Consistent with this, over half of the patients with hemophilia reported discussing carrier testing with at least some relatives prior to our approaching them about this study. Not only was there ongoing discussion of carrier testing in these families, but a majority of hemophilia patients felt an obligation to inform family members about the carrier testing available through our study. Part of such felt obligations may be due to the fact that the majority of relatives and patients interacted with each other with some frequency and, additionally, a large majority of relatives felt some degree of psychological closeness to the family member with hemophilia. Together, these factors likely contributed to a supportive and active family context regarding hemophilia A carrier testing.
Additionally, in our study a large majority of relatives reported that family members had some influence on their decision to have DNA-based carrier testing. In these families, not only were relatives a source of information about carrier testing, but many played a role in each other's decisions to proceed with DNA-based carrier testing. While such data are not definitive, they suggest that it was not taboo within these families to discuss carrier testing. Moreover, the large majority of patients and their relatives did not feel that our approaching their families was a violation of family privacy. While some families may object to being identified as members of families with a specific genetic disease, this appears not be have been the case for these families with hemophilia A.
Second, while there was a family context regarding carrier testing in our study population, in this study, as in several others reviewed above, the communication of genetic carrier testing information within families was selective, not universal. In our situation, the communication of carrier test results largely followed gender lines, which makes sense genetically for this X-linked diseases. Also, consistent with several of the studies reviewed above, it is clear that mothers are pivotal sources of discussion regarding carrier testing. This noted, it is important to emphasize that there were at-risk female relatives with whom results were not shared, including sisters. This reinforces the observation that families are social systems, and within these systems information is selectively communicated, influenced by the values, beliefs, and life experiences of the individual family members.
Third, while most women undergoing hemophilia carrier testing in this study reported that they had little concern about whether to inform relatives about their carrier results, nor which relatives to inform, nor when to inform relatives, including their own children, those individuals with a positive carrier test result were more likely to report such concerns. While we do not have data on the degree to which providers assist people who are identified as carriers with communicating that information to at-risk individuals, the results of our research suggest that it may be useful for providers to include such education and counseling in their session with patients.
Ultimately, the impact of genetic carrier testing rests not only on how the individuals tested react to such information, but also on whether such individuals share this information within their family network, and the support and reactions of the family network to such behavior. Research into ways of helping such people communicate the results of their testing to family members would be useful in developing more effective counseling and educational approaches. Such research would recognize the familial context of genetic carrier testing.
Acknowledgements
The authors acknowledge the contributions of Brian Cheuvront, Malcolm Douglas, Terri Spinney, and James Thrasher, as well as the assistance of the Hemophilia Clinics at the University of North Carolina at Chapel Hill and at Wake Forest University–Baptist Medical Center, Winston-Salem, NC. Supported by grants R01 HG01145 and R01 HG01767 from the National Human Genome Research Institute, National Institutes of Health (to J.R.S.).